Avanos Medical Inc (AVNS) support and resistance · rev $687.8M
Avanos Medical Inc (AVNS) is a medical devices company listed on NYSE.
This page maps Avanos Medical Inc (AVNS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported AVNS revenue for 2024-12-31 was $687.8M. Net income was -$392.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. AVNS currently screens at market cap $1.17B.
AVNS currently screens at market cap $1.17B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new AVNS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the AVNS quote page for the session range and the stock page for the full model.
Not investment advice.